Design and in vivo evaluation of a microparticulate depot formulation of buprenorphine for veterinary use.
Ontology highlight
ABSTRACT: Buprenorphine is a frequently used analgetic agent in veterinary medicine. A major drawback, however, is the short duration of action requiring several daily administrations. We therefore designed a poly-lactic-co-glycolic acid (PLGA) based microparticulate drug formulation for sustained parenteral drug release. Particles were designed to allow for a fast onset of action and a duration of the analgesic effect of at least two days in laboratory mice. Microparticles were produced using a solvent evaporation technique. Release rate was dependent on polymer type and particle size. Spherical particles used for subsequent animal studies had a mean size of 50 µm and contained 4.5% of buprenorphine. Drug release was characterized by an initial burst release of 30% followed by complete release over
SUBMITTER: Schreiner V
PROVIDER: S-EPMC7560740 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA